Setu joined atai Life Sciences in 2020. Previously, Dr. Kasera was a Biopharma Strategy Consultant at Catenion where she evaluated drug assets to advise VC clients.
Prior to that, she was Director of Operations at Chalante, an early-stage company focused on drug discovery in animal health, and Senior Technical & Business Analyst at Acidophil, a biotech focused on chemicals and drug discovery. During her postdoctoral training at University of Cambridge, UK, she led pre-commercialization activities for a co-invented sensor technology in medical diagnostics and received executive entrepreneurial training at Judge Business School.
Dr. Kasera holds a BSc in Biological Chemistry from Aston University, UK and, an MPhil and a Ph.D. in Chemistry from the University of Cambridge, UK.